Glutamine synthetase was confirmed as a target of miR-29A and was significantly reduced in the small bowel mucosa in IBS patients suggesting a relationship between miR-29a, glutamine dependent signaling pathways and intestinal permeability in IBS patients. This evidence concerns the gene GLUL and irritable bowel syndrome.